Anti-glatiramer acetate antibody levels in treated multiple sclerosis patients

被引：0
|
作者：
Oger, J [1 ]
Gibb, E [1 ]
Basile, E [1 ]
Aziz, T [1 ]
机构：
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷 / 01期
关键词：
enzyme linked immunosorbent assay; ELISA; glatiramer acetate (GA); immunoglobulin G; IgG; optical density; OD; peripheral blood mononuclear cells; PBMC; pokeweed mitogen; PWM;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [1] Anti-glatiramer acetate antibodies profile in long-term treated multiple sclerosis patients
    Brenner, T.
    Karusis, D.
    Abramsky, O.
    Sicsic, C.
    Arnon, R.
    Teitelbaum, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 28 - 28
  • [2] Long-term treatment of multiple sclerosis patients with glatiramer acetate: clinical efficacy and anti-glatiramer acetate antibodies profile
    Teitelbaum, D.
    Brenner, T.
    Abramsky, O.
    Sicsic, C.
    Arnon, R.
    Karussis, D.
    MULTIPLE SCLEROSIS, 2006, 12 : S98 - S99
  • [3] Comparison of In vivo toxicity and anti-glatiramer acetate IgG antibody titers in rats Treated with glatiramer acetate (Copaxone) and follow-on glatiramer acetate (FOGA) products
    Konya, A.
    Timan, B.
    Ashkenazi, N.
    Bursztyn, D.
    Gyure, L.
    Vardi, M.
    Alexander, J.
    Loupe, P.
    Nock, S.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 337 - 337
  • [4] Long Term Treatment of Multiple Sclerosis with Glatiramer Acetate: Natural History of the Subtypes of Anti-Glatiramer Acetate Antibodies and Their Correlation with Clinical Efficacy
    Brenner, Talma
    Teitelbaum, Dvora
    Sicsic, Camille
    Karussis, Dimitrios
    NEUROLOGY, 2010, 74 (09) : A423 - A423
  • [5] Panniculitis in multiple sclerosis patients treated with glatiramer acetate
    Sa, J
    Cordeiro, C
    MULTIPLE SCLEROSIS, 2005, 11 : S85 - S85
  • [6] Long-term treatment of multiple sclerosis with glatiramer acetate: Natural history of the subtypes of anti-glatiramer acetate antibodies and their correlation with clinical efficacy
    Karussis, Dimitros
    Teitelbaum, Dvora
    Sicsic, Camille
    Brenner, Talma
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 220 (1-2) : 125 - 130
  • [7] Clinical course of multiple sclerosis in Japanese patients treated with glatiramer acetate
    Okamoto, T.
    Lin, Y.
    Araki, M.
    Sato, W.
    Kawazoe, T.
    Wakasugi, N.
    Takewaki, D.
    Takahashi, Y.
    Yamamura, T.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 793 - 794
  • [8] Lipoatrophy in patients with multiple sclerosis on glatiramer acetate
    Edgar, CM
    Brunet, DG
    Fenton, P
    McBride, EV
    Green, P
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2004, 31 (01) : 58 - 63
  • [9] Prohibitin: prohibiting inflammation in glatiramer acetate-treated multiple sclerosis patients?
    Knop, Matthias
    Vargas-Leal, Vivian
    Faber, Hans
    Lutz, Sandra
    Mueller-Sarnowski, Felix
    Hornung, Joachim
    Turck, Christoph W.
    Weber, Frank
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 : S132 - S132
  • [10] T Cell Renewal in Glatiramer Acetate-Treated Multiple Sclerosis Patients
    Chiarini, Marco
    Capra, Ruggero
    Sottini, Alessandra
    Serana, Federico
    Ghidini, Claudia
    Zanotti, Cinzia
    Cordioli, Cinzia
    Rottoli, Maria Rosa
    Zaftoroni, Mauro
    Imberti, Luisa
    NEUROLOGY, 2009, 72 (11) : A36 - A36
12345